C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
The relative significance of residual beta-cell secretory activity and human insulin antibodies in determining diabetic stability has been examined in 35 diabetic subjects. The response of plasma C-peptide immunoreactivity following 50 g oral glucose has been used as an index of beta-cell function. Glucose-stimulated C-peptide secretion was observed in 58% of stable diabetics, but in no labile diabetics. When present, C-peptide secretion following a glucose load in diabetics was of smaller amplitude and slower in onset, but more prolonged than in normal subjects. In secretors, stability of diabetes was significantly correlated with the magnitude of the C-peptide response. As a group, labile diabetics had lower insulin antibody levels than stable patients, but stability and antibody levels were not correlated in individual patients. In non-secretors there was no difference in antibody levels between the stable and labile groups. Neither the equilibrium binding affinities nor the dissociation rate constants differed significantly for antibodies from stable and labile diabetics. Thus stability of diabetes depends upon residual beta-cell secretory activity, but not on the concentration or binding characteristics of insulin antibodies.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002096:C-Peptide / Q000378:metabolism*; D002648:Child; D003920:Diabetes Mellitus / Q000503:physiopathology*; D005951:Glucose Tolerance Test; D006801:Humans; D007330:Insulin Antibodies / Q000032:analysis*; D008875:Middle Aged; D010455:Peptides / Q000378:metabolism*
D002096:C-Peptide; D007330:Insulin Antibodies; D010455:Peptides